Fermatex returning to familiar Adam Spence name

Fermatex Vascular Technologies (Wall, N.J.) — formerly WL Gore Jersey Shore and most notably Adam Spence — said today that it is rebranding back to the Adam Spence name.

The name change will be effective June 4.

Company officials said that going back to the Adam Spence name will help the company benefit from Adam Spence’s long history of developing highly-engineered medical extrusions, braid and coil-reinforced tubing, and catheter sub-assemblies for major legacy medical device companies. WL Gore bought Adam Spence in 2004; Vance Street Capital acquired it in 2017.

The company is launching a new website to go along with the name change. 

“We’re thrilled to unveil our refreshed brand identity and redesigned website,“ said Steve Maxson, VP of marketing and sales at Adam Spence.

“The iconic name Adam Spence reflects the combination of our expanded fluoropolymer extrusion capabilities, our patent pending Fremat technology, a novel method to manufacture coreless high pressure braided tubing, and our comprehensive Quality Management System. It supports our vision to be a best in class contract manufacturer of Vascular Technologies to the medical device industry,” Maxson said.

Adam Spence plans to exhibit at MD&M East (Booth 1638), June 12–14 in New York City.

 

 

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW